Shanghai Oli Enterprises

Shanghai Oli-Oligo Biotechnology is a specialized Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) focused on the field of oligonucleotide therapeutics. Based in Shanghai, the company provides a comprehensive suite of services including the synthesis, modification, and purification of DNA and RNA sequences, such as siRNA, ASO, and mRNA. They support global pharmaceutical and biotechnology partners from the discovery phase through clinical development with high-quality raw materials and process development expertise. The company leverages advanced synthesis technologies and rigorous quality management systems to accelerate the development of nucleic acid-based medicines. Their capabilities include high-throughput synthesis and large-scale GMP production tailored for the evolving needs of the RNA therapeutics market.